» Articles » PMID: 37727989

Reversible Pulsed Electrical Fields As an In Vivo Tool to Study Cardiac Electrophysiology: The Advent of Pulsed Field Mapping

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background: During electrophysiological mapping of tachycardias, putative target sites are often only truly confirmed to be vital after observing the effect of ablation. This lack of mapping specificity potentiates inadvertent ablation of innocent cardiac tissue not relevant to the arrhythmia. But if myocardial excitability could be transiently suppressed at critical regions, their suitability as targets could be conclusively determined before delivering tissue-destructive ablation lesions. We studied whether reversible pulsed electric fields (PF) could transiently suppress electrical conduction, thereby providing a means to dissect tachycardia circuits in vivo.

Methods: PF energy was delivered from a 9-mm lattice-tip catheter to the atria of 12 swine and 9 patients, followed by serial electrogram assessments. The effects on electrical conduction were explored in 5 additional animals by applying PF to the atrioventricular node: 17 low-dose (PF) and 10 high-dose (PF) applications. Finally, in 3 patients manifesting spontaneous tachycardias, PF was applied at putative critical sites.

Results: In animals, the immediate post-PF electrogram amplitudes diminished by 74%, followed by 78% recovery by 5 minutes. Similarly, in patients, a 69.9% amplitude reduction was followed by 84% recovery by 3 minutes. Histology revealed only minimal to no focal, superficial fibrosis. PF at the atrioventricular node resulted in transient PR prolongation and transient AV block in 59% and 6%, while PF caused transient PR prolongation and transient AV block in 30% and 50%, respectively. The 3 tachycardia patients had atypical atrial flutters (n=2) and atrioventricular nodal reentrant tachycardia. PF at putative critical sites reproducibly terminated the tachycardias; ablation rendered the tachycardias noninducible and without recurrence during 1-year follow-up.

Conclusions: Reversible electroporation pulses can be applied to myocardial tissue to transiently block electrical conduction. This technique of pulsed field mapping may represent a novel electrophysiological tool to help identify the critical isthmus of tachycardia circuits.

Citing Articles

Using a Novel Pulsed Field Ablation Technique to Identify the Critical Isthmus Within a Tachycardia Circuit.

Mannion J, Rathore F, David J, Lyne J J Innov Card Rhythm Manag. 2025; 16(2):6195-6198.

PMID: 40052006 PMC: 11882119. DOI: 10.19102/icrm.2025.16023.


Biophysics and electrophysiology of pulsed field ablation in normal and infarcted porcine cardiac ventricular tissue.

Miklavcic D, Verma A, Krahn P, Stublar J, Kos B, Escartin T Sci Rep. 2024; 14(1):32063.

PMID: 39738639 PMC: 11686391. DOI: 10.1038/s41598-024-83683-y.


State-of-the-art pulsed field ablation for cardiac arrhythmias: ongoing evolution and future perspective.

Chun K, Miklavcic D, Vlachos K, Bordignon S, Scherr D, Jais P Europace. 2024; 26(6).

PMID: 38848447 PMC: 11160504. DOI: 10.1093/europace/euae134.


Efficacy and safety of pulsed field ablation for accessory pathways: a pilot study.

Shen C, Jia Z, Yu Y, Feng M, Du X, Fu G Europace. 2024; 26(7).

PMID: 38801673 PMC: 11218562. DOI: 10.1093/europace/euae139.


A real-world case-control study on the efficacy and safety of pulsed field ablation for atrial fibrillation.

Yang M, Wang P, Hao Y, Liang M, Yu Z, Li X Eur J Med Res. 2023; 28(1):519.

PMID: 37968748 PMC: 10648358. DOI: 10.1186/s40001-023-01509-5.

References
1.
Koruth J, Kuroki K, Iwasawa J, Enomoto Y, Viswanathan R, Brose R . Preclinical Evaluation of Pulsed Field Ablation: Electrophysiological and Histological Assessment of Thoracic Vein Isolation. Circ Arrhythm Electrophysiol. 2019; 12(12):e007781. PMC: 6924932. DOI: 10.1161/CIRCEP.119.007781. View

2.
DeBruin K, Krassowska W . Modeling electroporation in a single cell. II. Effects Of ionic concentrations. Biophys J. 1999; 77(3):1225-33. PMC: 1300414. DOI: 10.1016/S0006-3495(99)76974-2. View

3.
Ekanem E, Reddy V, Schmidt B, Reichlin T, Neven K, Metzner A . Multi-national survey on the methods, efficacy, and safety on the post-approval clinical use of pulsed field ablation (MANIFEST-PF). Europace. 2022; 24(8):1256-1266. PMC: 9435639. DOI: 10.1093/europace/euac050. View

4.
Skanes A, Dubuc M, Klein G, Thibault B, Krahn A, Yee R . Cryothermal ablation of the slow pathway for the elimination of atrioventricular nodal reentrant tachycardia. Circulation. 2000; 102(23):2856-60. DOI: 10.1161/01.cir.102.23.2856. View

5.
Koruth J, Kuroki K, Kawamura I, Stoffregen W, Dukkipati S, Neuzil P . Focal Pulsed Field Ablation for Pulmonary Vein Isolation and Linear Atrial Lesions: A Preclinical Assessment of Safety and Durability. Circ Arrhythm Electrophysiol. 2020; 13(6):e008716. DOI: 10.1161/CIRCEP.120.008716. View